Compare Indonesian Paradise Property Tbk (INPP) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indonesian Paradise Property Tbk vs Tempo Scan Pacific Tbk. — how do they compare? Indonesian Paradise Property Tbk trades at Rp765 (market cap 8.39T, 178.1K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,780 (market cap 12.58T, 226.9K 24h volume). The key difference: Tempo Scan Pacific Tbk. is the larger of the two by market cap, and Tempo Scan Pacific Tbk. is more actively traded (226.9K versus 178.1K). Which is the better fit depends on your goals.
| INPP | TSPC | |
|---|---|---|
Market Cap | 8.39T | 12.58T |
Volume | 178.1K | 226.9K |
Lot | 1.78K | 2.27K |
Turnover | 134.86M | 626.87M |
Average Price | 757.21 | 2,762.77 |
Value | 134.86M | 626.87M |
Indicative Equilibrium Price | 750 | 2,790 |
Indicative Equilibrium Volume | 1.1K | 3.9K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indonesian Paradise Property Tbk
PT. Indonesia Paradise Property Tbk (the Company) was established under the name of PT Penta Karsa Lubrindo based on Notarial Deed No. 96 dated June 14, 1996 of Buntario Tigris Darmawa, NG, S.H., CN., and was amended of Rachmat Santoso, S.H., Public Notary in Jakarta. The Company is an Indonesia-based company engaged in the property sector, hotel operation, general contractor and general trading. The Company's hotel is located in Bali, Indonesia.
Read more on INPP →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
